Having trouble finding Sotyktu at your pharmacy? Learn why this psoriasis medication is so hard to find in 2026 and what you can do about it.
You finally got your prescription for Sotyktu (Deucravacitinib) — the first-in-class oral TYK2 inhibitor for plaque psoriasis — and now your pharmacy says they don't have it. Sound familiar?
Patients across the country have reported the same frustrating experience. Despite being FDA-approved since September 2022, Sotyktu remains surprisingly difficult to find at many pharmacies in 2026. In this article, we'll explain why — and more importantly, what you can do about it.
Sotyktu is the brand name for Deucravacitinib, a once-daily oral tablet (6 mg) used to treat moderate-to-severe plaque psoriasis in adults. Unlike older treatments that require injections, Sotyktu is a pill you take by mouth every day.
It works by selectively blocking an enzyme called TYK2, which plays a key role in the immune system's inflammatory response. By targeting TYK2 specifically, Sotyktu reduces inflammation without broadly suppressing the immune system the way traditional JAK inhibitors do. This is why it doesn't carry the same boxed warning seen with drugs like Xeljanz or Rinvoq.
There are several reasons you might struggle to fill your Sotyktu prescription. Here are the most common ones:
Sotyktu is classified as a specialty medication. That means it's not typically stocked on the shelf at your local CVS, Walgreens, or Rite Aid the way common prescriptions are. Instead, Bristol-Myers Squibb (BMS) distributes Sotyktu primarily through specialty pharmacies — pharmacies that focus on high-cost, complex medications.
This limited distribution model means that even if your doctor sends the prescription to your regular pharmacy, they may not carry it and may not be able to order it quickly.
Sotyktu costs approximately $2,000 to $2,400 per month without insurance. Most retail pharmacies are reluctant to keep such an expensive medication in stock because if a patient doesn't pick it up, the pharmacy is stuck with a high-value product sitting on the shelf. This financial risk means pharmacies only order it when they have a confirmed prescription and patient.
Most insurance plans require prior authorization before they'll cover Sotyktu. Many also require step therapy, meaning you must have tried and failed other treatments first (such as Methotrexate, phototherapy, or a biologic). These approval processes can take days or weeks, creating delays that make it seem like the drug is unavailable when it's actually an insurance issue.
Although Sotyktu was approved in 2022, it's still gaining traction among dermatologists and patients. Many pharmacies haven't built up regular demand, so they simply don't stock it. As more prescribers become familiar with the drug and more patients request it, availability should gradually improve.
If you're having trouble finding Sotyktu, here are some practical steps:
Medfinder lets you search for pharmacies that currently have Sotyktu in stock near your location. It's the fastest way to avoid calling pharmacy after pharmacy.
Your dermatologist's office likely has relationships with specialty pharmacies that regularly dispense Sotyktu. Ask your provider to send the prescription directly to a specialty pharmacy, which can often ship the medication to your door.
Independent pharmacies are sometimes more willing to special-order medications like Sotyktu. They may also offer more personalized service in helping you navigate insurance approvals. Check our guide on how to find Sotyktu in stock near you for more tips.
Bristol-Myers Squibb has a dedicated patient support program that can help connect you with pharmacies that carry Sotyktu and assist with insurance issues. Visit their website or ask your doctor's office to help you enroll.
Finding Sotyktu can be frustrating, but the difficulty usually comes down to its specialty distribution model, high cost, and insurance hurdles — not an actual drug shortage. With the right tools and a little persistence, most patients can get their prescription filled.
Start by checking Medfinder for real-time stock information, talk to your dermatologist about specialty pharmacy options, and don't hesitate to explore savings programs if cost is a barrier.
For a deeper look at the current availability situation, read our Sotyktu shortage update for 2026.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
